Company news

Botanix Pharmaceuticals Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Australian Ethics approval for Acne Study

June 12, 2018

BTX 1204 Atopic Dermatitis Study Results Presentation

June 6, 2018

Botanix Announces Successful Atopic Dermatitis Study Results

June 5, 2018

Presentation on Atopic Dermatitis Market

May 22, 2018

FDA Green Light for BTX 1503 Phase 2 Study

May 7, 2018

Appendix 4C - quarterly

April 24, 2018

Enrolment of BTX 1204 Atopic Dermatitis Study Completed

April 9, 2018

Completion of Placement

February 11, 2018

Significantly Oversubscribed A$15m Placement

February 4, 2018

Botanix Announces Successful Acne Study Results

January 28, 2018

Botanix Receives A$1.6m R&D Tax Incentive Refund

January 15, 2018

Botanix Completes Enrolment of BTX 1503 Acne Patient Study

December 17, 2017

New Antibacterial Results Support BTX 1503 Acne Program

December 4, 2017

Botanix Enrols First Patients in Dermatitis Study

November 22, 2017

Botanix Commences BTX 1204 Dermatitis Patient Study

October 30, 2017

FDA Clears Development Path for BTX 1503

October 8, 2017

Botanix Commences BTX 1503 Acne Patient Study

August 20, 2017

Botanix Completes Successful Phase 1 BTX 1503 Clinical Study

July 3, 2017

12 Month Operational Review Highlights Significant Progress

June 26, 2017

Successful Pilot Study for BTX 1701 Facial Cleanser

June 7, 2017

Completion of Tranche 2 of Capital Raising Placement

May 19, 2017

Botanix Commences First Clinical Study for BTX 1503

May 7, 2017

Completion of the Tranche 1 Placement

April 12, 2017

Reinstatement to official quotation

April 4, 2017

Suspension from Official Quotation

April 3, 2017

Botanix Receives Approval for Synthetic Cannabidiol Trial

March 29, 2017

Export and Import Approvals for Clinical Studies Received

March 23, 2017

Botanix Announces Filing of New Permetrex Product Patents

February 26, 2017

Botanix Announces Expansion of Permetrex License

February 2, 2017

Quarterly Cashflow Report

January 30, 2017

Botanix Announces Positive Human Trial Data

December 6, 2016

Botanix Accelerates Clinical Program with First Human Study

November 10, 2016

DEA Scheduling Decision Supports Botanix Approach

August 14, 2016

Botanix Secures Commercial-Scale Synthetic Cannabidiol

July 28, 2016

Reinstatement to Official Quotation - 15 July 2016

July 13, 2016

Suspension

June 13, 2016

Prospectus - Botanix Pharmaceuticals

May 13, 2016

Human Clinical Study for an Oral Treatment for Osteoporosis

March 30, 2016

Acquisition of Botanix Pharmaceuticals Inc

March 20, 2016

Termination of Agreement to acquire Takor

February 11, 2016

Takor Update - Mappt Update & Collaboration Opportunities

February 10, 2016

← Newer news releases

Calls

Decks

The 5 newest of 62 decks. Every deck is listed under its year.